Out-Licensing Opportunity

Objective :

Licensing Partners Identification for client’s proprietary technology based neonatal MSCsOpportunity Assessment through Secondary & Primary Intelligence.

Problem Statement:

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from across the globe. They wished to identify a potential list of companies, to become a fit for their neonatal high quality MSCs and can prove to be a good business partner as a licensee for their proprietary “API” of the stem cell therapy domain.

Our Methodology:

• Stem Cell Market Assessment
• Companies Assessment Portfolio Assessment
• Deal/Investment Assessment
• Interest in Client’s MSC
• 20 Potential Partners

Results:

• Matrix Analysis positioned the top 20 companies researched.
• The client could assess the Top companies which would effectively fit their strategic needs and objectives (the TARGET quadrant).
• DelveInsight fixed meetings with these probably 4-5 companies for the client to take discussions forward.